sale acceler could shift
sale beat shift debat pg consum stapl
pg organ sale acceler y/i best sinc gm
y/i commod /- line quell notion pg bought
sale importantli price flat guid neg sequenti improv expect
pg help build case price uplift first discuss across hpc last quarter
could materi share close biggest move decad believ part
attribut low expect share price weak result
management indic peer-best tracked-channel data would off-set promot
inventori build ahead plan price action also potenti helper howev
pg result certainli boost consum stapl specif hpc support
notion volum growth potenti price well sector role defens
rais organ sale vs prior flow
beat well higher forecast pg maintain organ sale
outlook despit above-rang start call tougher comp
well uncertainti volum impact price implement inde
estim volum vs price correl sinc howev even
modest price expect vs prior pg posit reach
high-end target rang view forecast report sale
rais expect organ sale mostli off-set wors fx all-in
ep y/i vs maintain guidanc y/i
sustain key maintain neutral po
sustain pg improv result key question market concern prior
green shoot follow subsequ underwhelm result see next
month analyst meet well intra-quart tracked-channel data especi
import help indic whether hpc group potenti inflect price
come headwind eas like de-stock whether pg simpli take
share categori still see sluggish growth maintain neutral rate
rais po price-to-earnings reflect stronger sale
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
procter gambl pg one world largest
consum product compani oper five
babi famili
ariel alway tampax downi dawn
 industri bellweth consum
stapl industri owe diversifi product
portfolio multi-billion brand lead global
share posit long-term expect
compani scale global presenc
provid advantag howev recent
increas sale margin
pressur biggest categori countri
like necessit invest restor
ep vs bofaml/street upsid rel
model driven stronger top line
organ sale y/i vs bofaml/street driven volum
line mix vs flat price flat vs
segment beauti remain strongest segment organ sale y/i vs
led outsiz sk-ii growth y/i babi feminin famili
laggard y/i line expect remain three segment
outperform fabric vs health vs flat
tabl pg y/i perform segment categori
compani data note organ volum price mix may add total organ sale due round
overal strong innov retail execut
dm growth behind premium innov solid retail execut
em growth behind premium innov increas price
overal growth driven premium innov outsiz growth sk-ii olay
skin dd safeguard old spice olay secret msd
em led strong growth olay skin sk-ii china
dm growth behind premium product innov sk-ii dd japan
overal growth driven innov improv valu proposit e-comm
invest increas price certain market
em strength behind solid retail execut inflation-bas price
overal growth driven strong merchandis solid underli market growth
overal growth driven innov merchandis invest
dm growth behind innov power toothbrush premium toothpast off-set
part revers us toothpast list price increas
em growth behind premium toothpast off-set china low-tier toothpast declin
overal growth driven innov price increas vick strong
doubl digit exit pgt healthcar partnership headwind net sale
overal growth driven innov merchandis program
dm strength behind innov laundri fabric enhanc
em strength behind premium innov inflat base price
overal growth driven segment behind innov strong merchandis
improv brand commun
overal declin driven weak sale mid valu tier product especi
us china price reduct notabl luv us market partli
off-set growth premium-ti innov incl tape diaper pant
overal growth driven innov disproportion growth premium
pad alway discreet adult incontin product
guid organ sale core ep unchang
pg maintain guidanc organ sale y/i expect net sale
flat vs prior flat less favor fx outlook hit sale
vs prior hit pg continu expect core ep y/i impli
base inclus tax profit headwind fx
commod vs prior cadenc margin improv back half
price hit market late save build throughout year help
fx sale
interest expense/incom non-oper incom
fx commod after-tax incom
flat
chang
chang
chang
chang
chang
chang
ep growth
flat
good sold report
good sold
sale
sale
good sold report
good sold
sale
sale
sale
depreci amort
ep charg dilut
price object base ep estim vs target
large-cap hpc group pg taken number action turn around result
progress taken longer expect visibl turn improv
mind believ market need see multipl quarter improv
result pg share see sustain uptrend longer term continu
see pg scale differenti innov portfolio brand strength key
advantag valuat oner rel histor level
upsid risk price object improv oper backdrop drive
faster expect turnaround sale downsid risk sustain sale
sluggish broad price pressur drive earn eros
olivia tong cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
helen troy
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
